Thomas Hazel is the Vice President of Scientific Operations at BullFrog AI, where he
served as the VP of Drug Development from 2021 until 2026. Prior to that, he served as
Senior VP of Research and Development at Seneca Biopharma. Thomas received a
B.A. in Biology from Kalamazoo College and a Ph.D. in Genetics from the University of
Illinois Chicago.
